Deconstructing the Kaplan-Meier curve: Quantification of treatment effect using the treatment effect process Journal Article


Authors: Devlin, S. M.; O'Quigley, J.
Article Title: Deconstructing the Kaplan-Meier curve: Quantification of treatment effect using the treatment effect process
Abstract: In studies of survival and its association with treatment and other prognostic variables, elapsed time alone will often show itself to be among the strongest, if not the strongest, of the predictor variables. Kaplan-Meier curves will show the overall survival of each group and the general differences between groups due to treatment. However, the time-dependent nature of treatment effects is not always immediately transparent from these curves. More sophisticated tools are needed to spotlight the treatment effects. An important tool in this context is the treatment effect process. This tool can be potent in revealing the complex myriad of ways in which treatment can affect survival time. We look at a recently published study in which the outcome was relapse-free survival, and we illustrate how the use of the treatment effect process can provide a much deeper understanding of the relationship between time and treatment in this trial. © 2022 Elsevier Inc.
Keywords: gene mutation; placebo; treatment duration; cancer staging; melanoma; therapy effect; hazard ratio; kaplan meier method; kaplan-meier survival curves; b raf kinase; biostatistics; clinical trials; recurrence free survival; randomized controlled trial (topic); phase 3 clinical trial (topic); dabrafenib; trametinib; human; article
Journal Title: Contemporary Clinical Trials
Volume: 125
ISSN: 1551-7144
Publisher: Elsevier Inc.  
Date Published: 2023-02-01
Start Page: 107043
Language: English
DOI: 10.1016/j.cct.2022.107043
PUBMED: 36473681
PROVIDER: scopus
PMCID: PMC9918692
DOI/URL:
Notes: Article -- Export Date: 3 January 2023 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sean McCarthy Devlin
    601 Devlin